These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Electrical storm of monomorphic ventricular tachycardia after a cardiac-resynchronization-therapy-defibrillator upgrade. Kantharia BK; Patel JA; Nagra BS; Ledley GS Europace; 2006 Aug; 8(8):625-8. PubMed ID: 16772367 [TBL] [Abstract][Full Text] [Related]
6. Treatment of ventricular arrhythmias after recovery from myocardial infarction. Mitchell LB Annu Rev Med; 1994; 45():119-38. PubMed ID: 7515218 [TBL] [Abstract][Full Text] [Related]
7. Dofetilide reduces the frequency of ventricular arrhythmias and implantable cardioverter defibrillator therapies. Baquero GA; Banchs JE; Depalma S; Young SK; Penny-Peterson ED; Samii SM; Wolbrette DL; Naccarelli GV; Gonzalez MD J Cardiovasc Electrophysiol; 2012 Mar; 23(3):296-301. PubMed ID: 21955243 [TBL] [Abstract][Full Text] [Related]
8. Pharmacologic and nonpharmacologic treatment of ventricular arrhythmias in heart failure. Stevenson WG; Sweeney MO Curr Opin Cardiol; 1997 May; 12(3):242-50. PubMed ID: 9243081 [TBL] [Abstract][Full Text] [Related]
9. Etiology and management of sustained ventricular tachycardia. Talwar KK; Naik N Am J Cardiovasc Drugs; 2001; 1(3):179-92. PubMed ID: 14728033 [TBL] [Abstract][Full Text] [Related]
10. Identification and management of ventricular tachycardia. Naik N; Talwar KK J Indian Med Assoc; 2003 Feb; 101(2):62-5, 95. PubMed ID: 12841484 [TBL] [Abstract][Full Text] [Related]
11. [Eleven-years long follow-up in a patient after myocardial infarction, with low ejection fraction and recurrent ventricular tachycardia. The role of implantable cardioverter defibrillator and selective ablation]. Przybylski A; Derejko P; Iwanek M; Urbanek P; Kepski R; Grzybowski J; Chojnowska L; Szumowski Ł; Szwed H; Walczak F Kardiol Pol; 2006 Jul; 64(7):758-62. PubMed ID: 16886137 [TBL] [Abstract][Full Text] [Related]
12. A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators. Buxton AE; Lee KL; Fisher JD; Josephson ME; Prystowsky EN; Hafley G N Engl J Med; 1999 Dec; 341(25):1882-90. PubMed ID: 10601507 [TBL] [Abstract][Full Text] [Related]
13. [Long-term outcome of pharmacological and nonpharmacological treatment for ventricular arrhythmias]. Ohnishi S; Kasanuki H J Cardiol; 2000 Mar; 35 Suppl 1():75-84. PubMed ID: 10834174 [TBL] [Abstract][Full Text] [Related]
14. Verapamil-sensitive left ventricular tachycardia in patients with coronary artery disease: clinical and electrophysiologic features consistent with triggered activity. Sorbera C; Cohen M; Kuznetsov V; Dhakham S Heart Dis; 1999; 1(1):2-7. PubMed ID: 11720598 [TBL] [Abstract][Full Text] [Related]
15. Catheter Ablation of Ventricular Tachycardia as the First-Line Therapy in Patients With Coronary Artery Disease and Preserved Left Ventricular Systolic Function: Long-Term Results. Clemens M; Peichl P; Wichterle D; Pavlů L; Čihák R; Aldhoon B; Kautzner J J Cardiovasc Electrophysiol; 2015 Oct; 26(10):1105-10. PubMed ID: 26179108 [TBL] [Abstract][Full Text] [Related]
17. Current approaches to evaluation and management of patients with ventricular arrhythmias. Buxton AE; Kirk MM; Michaud GF Med Health R I; 2001 Feb; 84(2):58-62. PubMed ID: 11272662 [TBL] [Abstract][Full Text] [Related]
20. [Arrhythmia recurrence in patients with an old myocardial infarct treated by implantable defibrillator: an analysis according to the initial clinical presentation]. Vacca M; Mont L; Valentino M; Sambola A; Madariaga R; Matas M; Brugada J Rev Esp Cardiol; 1999 Dec; 52(12):1066-74. PubMed ID: 10659653 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]